AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Itaglipt M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Newgen Pharma

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Itaglipt M 500mg/50mg Tablet

Itaglipt M 500mg/50mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate severe diabetic complications like vision impairment and kidney dysfunction, potentially lessening the risk of cardiovascular events such as stroke or heart attack. Itaglipt M 500mg/50mg tablets may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved when coupled with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and concurrent medications. Consuming the medication with food minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. This treatment helps regulate blood sugar, reducing the likelihood of future complications. Adherence to your physician's dietary and exercise plan is crucial; lifestyle choices significantly impact diabetes management. Common side effects can include nausea, vomiting, diarrhea, indigestion, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect when used with insulin or sulfonylureas; learn to recognize and treat this complication. This medication isn't suitable for all patients. Inform your doctor of any history of cardiac, hepatic, or renal disease, pancreatic issues, or significant alcohol consumption prior to commencing treatment. Pregnant or lactating individuals should seek medical counsel. Interaction with other medications is possible; disclose all your medications to ensure safety. Alcohol should be minimized due to its potential to lower blood glucose. Your doctor will monitor kidney function and blood glucose levels throughout your treatment.

Primary Ingredients of Itaglipt M 500mg/50mg Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Itaglipt M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Itaglipt M 500mg/50mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 500mg/50mg Itaglipt M Tablet whole; do not break, crush, or chew it. Administer this medication with a meal.

Common Side effects of Itaglipt M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Itaglipt M 500mg/50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 500mg/50mg Itaglipt M tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Itaglipt M 500mg/50mg Tablet works:

The tablet Itaglipt M, containing 500mg/50mg of a dual-action antidiabetic formulation, combines two distinct medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Itaglipt M 500mg/50mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Itaglipt M 500mg/50mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Ittaglipt M 500mg/50mg Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Itaglipt M 500mg/50mg Tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

The use of Itaglipt M 500mg/50mg tablets in individuals with hepatic impairment is likely inadvisable and should be avoided. Medical guidance is recommended.

What if you forget to take Itaglipt M 500mg/50mg Tablet :

Should you forget to take your Itaglipt M 500mg/50mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Itaglipt M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Itaglipt M 500mg/50mg Tablet

Itaglipt M 500mg/50mg tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate caloric intake while using this medication. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are skipped or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Itaglipt M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Itaglipt M 500mg/50mg Tablets are contraindicated in patients allergic to any of its components or excipients. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Itaglipt M 500mg/50mg tablets combine metformin (a biguanide) and vildagliptin, both used to treat diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is unsuitable for individuals under 18.
Itaglipt M 500mg/50mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms occur, discontinue Itaglipt M 500mg/50mg Tablets and seek immediate medical attention.
Prolonged use of Itaglipt M 500mg/50mg tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Using Itaglipt M 500mg/50mg Tablet as directed by your doctor is safe. However, even with proper use, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (hypoglycemia, especially when combined with insulin or sulfonylurea) may occur. Report any persistent issues to your doctor.
Itaglipt M 500mg/50mg Tab...
89
MRP 108
17% off